Abstract:BackgroundCerebral hypoperfusion is a pivotal risk factor for vascular dementia (VD), for which effective therapy remains inadequate. Persistent inflammatory responses and excessive chemotaxis of microglia/macrophages in the brain may accelerate the progression of VD. Endocannabinoids are involved in neuronal protection against inflammation-induced neuronal injury. Cannabinoids acting at cannabinoid receptor 2 (CB2R) can decrease inflammation. Based on the identification of paeoniflorin (PF) as a CB2R agonist, we investigated the neuroprotective and microglia/macrophages M1 to M2 polarization promoting effects of PF in a permanent four-vessel occlusion rat model.MethodsOne week after surgery, PF was intraperitoneally administered at a dose of 40 mg/kg once a day for 28 successive days. The effects of PF on memory deficit were investigated by a Morris water maze test, and the effects of PF on hippocampal neuronal damage were evaluated by light microscope and electron microscope. The mRNA and protein expression levels of key molecules related to the M1/M2 polarization of microglia/macrophages were assessed by RT-qPCR and Western blotting, respectively.ResultsAdministration of PF could significantly attenuate cerebral hypoperfusion-induced impairment of learning and memory and reduce the morphological and ultrastructural changes in the hippocampal CA1 region of rats. Moreover, PF promoted an M1 to M2 phenotype transition in microglia/macrophages in the hippocampus of rats. In addition to its inhibitory property against proinflammatory M1 mediator expression, such as IL-1β, IL-6, TNF-α and NO, PF dramatically up-regulated expression of anti-inflammatory cytokines IL-10 and TGF-β1. Importantly, CB2R antagonist AM630 abolished these beneficial effects produced by PF on learning, memory and hippocampus structure in rats, as well as the polarization of microglia/macrophages to the M2 phenotype. Additionally, PF treatment significantly inhibited cerebral hypoperfusion-induced mTOR/NF-κB proinflammatory pathway and enhanced PI3K/Akt anti-inflammatory pathway. Effects of PF on these signaling pathways were effectively attenuated when rats were co-treated with PF and AM630, indicating that the mTOR/NF-κB and PI3K/Akt signaling pathways were involved in the PF effects through CB2R activation.ConclusionThese findings demonstrated PF exerts its neuroprotective effect and shifts the inflammatory milieu toward resolution by modulation of microglia/macrophage polarization via CB2R activation.

Dual Activities of PAF in Central Nervous System and Its Values in Development of New Drugs

Effect of intraperitoneal pentobarbital injection or isoflurane inhalation anesthesia on the rat acute stress response

Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases

PMS777, A Bis-interacting Ligand for PAF Receptor Antagonism and AChE Inhibition, Attenuates PAF-induced Neurocytotoxicity in SH-SY5Y Cells

[Effect of Platelet-Activating Factor on Long-Term Potentiation in Rat Hippocampal Slices].

Role of platelet activating factor in diagnosis and treatment of acute cerebral infarction

Pathological Effects of Platelet-Activating Factor and Its Receptor after Cerebral Ischemia/reperfusion Injury in Rats

Down-Regulation of Platelet-Activating Factor Receptor Gene Expression During Focal Reversible Cerebral Ischemia in Rats

Platelet-activating factor. A putative mediator in central nervous system injury?

Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2

Yin and Yang of PDGF-mediated Signaling Pathway in the Context of HIV Infection and Drug Abuse

The Protective Effects of Up-Regulating Prostacyclin Biosynthesis on Neuron Survival in Hippocampus

Pharmacological Profile of Pms777, A New Ache Inhibitor with Paf Antagonistic Activity

Protective mechanism of Paeonol on central nervous system

Prostaglandins and other lipid mediators in Alzheimer's disease

Platelet Activating Factor-Induced Neuronal Apoptosis is Initiated Independently of Its G-Protein Coupled Paf Receptor and is Inhibited by the Benzoate Orsellinic Acid

Influence of Platelet-Activating Factor on Cardiovascular System

Blood-brain Barrier Breakdown by PAF and Protection by XQ-1H Due to Antagonism of PAF Effects.

Effect Of Recombinant Human Platelet Activating Factor Acetyl Hydrolase On Cpg15 Expression After Cerebral Ischemia

Recent Insights Into the Protective Mechanisms of Paeoniflorin in Neurological, Cardiovascular, and Renal Diseases

Molecular basis for the activation of PAF receptor by PAF